Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: A decade of experience

QJM: An International Journal of Medicine

Volumn 101, Issue 6, 2008, Pages 493-501

  Masson, Steven ^a   Mardini, H A ^a   Rose, J D ^a   Record, C O ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DIURETIC AGENT; LACTULOSE; POLITEF; PSYCHOTROPIC AGENT;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BLEEDING; CAUSE OF DEATH; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG WITHDRAWAL; ENDOSCOPIC THERAPY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MATERIAL COATING; PATIENT SELECTION; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; STENT; SURVIVAL TIME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; VARICOSIS;

EID: 44849130094     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn037     Document Type: Article

References (41)

1. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: Randomized trials for secondary prophylaxis of variceal bleeding: An updated meta-analysis. Scand J Gastroenterol 2002; 37:249-52.
2. Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212:411-21.
3. Khan S, Tudur SC, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev 2006; CD000553.
4. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 1999; 30:612-22.
5. Rees CJ, Rose JD, Record CO, Day CP, Bassendine MF, James OF, et al Transjugular intrahepatic portosystemic shunt: A limited role in refractory ascites. Eur J Gastroenterol Hepatol 1997; 9 969-73.
6. Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40:629-35.
7. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-7.
8. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al The North American Study for the treatment of refractory ascites. Gastroenterology 2003; 124:634-41.
9. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath P. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123 1839-47.
10. Saab S, Nieto JM, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2006; CD004889.
11. D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis. Gastroenterology 2005; 129:1282-93.
12. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995; 23:123-8.
13. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology 1994; 20:46-55.
14. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts JP, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk factors. Am J Gastroenterol 1995; 90:549-55.
15. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716-21.
16. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53:758-63.
17. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13:361-77.
18. Weissenborn K. Minimal hepatic encephalopathy: A permanent source of discussion. Hepatology 2002; 35:494-6.
19. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16:37-41.
20. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10:239-48.
21. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96:2718-23.
22. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III Shiffman ML, DeMeo J, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-98.
23. Haskal ZJ. Improved patency of transjugular intrahepatic portosystemic shunts in humans: Creation and revision with PTFE stent-grafts. Radiology 1999; 213:759-66.
24. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: Results of a randomized study. Gastroenterology 2004; 126:469-75.
25. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, et al Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114:1296-303.
26. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34:768-73.
27. Mardini H, Saxby B, Record CO. Computerised or paper and pencil tests for the assessment of hepatic encephalopathy. In: Hassinger D, Kircheis G, Schleiss F, eds. Hepatic Encephalopathy and Nitrogen Metabolism Springer, Dordrecht, 2006:474-80.
28. Ware JE Jr Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
29. McHorney CA, Ware JE Jr Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31:247-63.
30. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45:295-300.
31. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: The impact of type and severity of disease. Am J Gastroenterol 2001; 96 2199-205.
32. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-9.
33. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652-9.
34. Tripathi D, Helmy A, Macbeth K, Balata S, Lui HF, Stanley AJ, et al Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol 2004; 16:9-18.
35. Saravanan R, Nayar M, Gilmore IT, Smart H, McWilliams RG, Rowlands PC, et al. Transjugular intrahepatic portosystemic stent shunt: 11 years' experience at a regional referral centre. Eur J Gastroenterol Hepatol 2005; 17:1165-71.
36. Nolte, W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients electroencephalographic investigations. Hepatology 1998; 28:1215-25.
37. Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum RA, Redd DC. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195:485-8.
38. Kochar NJ, Tripathi, D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPPS refractory hepatic encehalopathy. Gut 2006; 55:1617-23.
39. Kramer L, Bauer E, Gendo A, Funk G, Madl C, Pidlich J, et al. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2002, 97:162-6.
40. Lockwood AH. "What's in a name?" Improving the care of cirrhotics. J Hepatol 2000; 32:859-61.
41. Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology 2000; 31:358-63.